celecoxib has been researched along with vortioxetine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Baune, BT; Fourrier, C; Mills, NT; Sampson, E | 1 |
Baune, BT; Clark, SR; Fourrier, C; Hori, H; Louise, J; Mills, NT; Sampson, E; Schubert, KO | 1 |
Courtet, P; Guillaume, S; Lengvenyte, A; Olie, E; Strumila, R | 1 |
Baune, BT; Fourrier, C | 1 |
Baune, BT; Clark, SR; Fourrier, C; Hohoff, C; Hori, H; Mills, NT; Sampson, E; Schubert, O; Schwarte, K | 1 |
3 trial(s) available for celecoxib and vortioxetine
Article | Year |
---|---|
Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Biomarkers; C-Reactive Protein; Celecoxib; Clinical Protocols; Cognition; Cyclooxygenase 2 Inhibitors; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Inflammation Mediators; Male; Middle Aged; Prospective Studies; Research Design; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Victoria; Vortioxetine; Young Adult | 2018 |
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial.
Topics: Antidepressive Agents; Australia; C-Reactive Protein; Celecoxib; Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Inflammation; Treatment Outcome; Vortioxetine | 2021 |
Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Topics: C-Reactive Protein; Celecoxib; Cognition; Depressive Disorder, Major; Double-Blind Method; Humans; Treatment Outcome; Vortioxetine | 2023 |
2 other study(ies) available for celecoxib and vortioxetine
Article | Year |
---|---|
Null effect of vortioxetine augmentation with celecoxib should not be generalized to other antidepressants.
Topics: Antidepressive Agents; Celecoxib; Selective Serotonin Reuptake Inhibitors; Vortioxetine | 2022 |
Null effect of vortioxetine augmentation with celecoxib should not be generalized to other antidepressants - Author's reply.
Topics: Antidepressive Agents; Celecoxib; Selective Serotonin Reuptake Inhibitors; Vortioxetine | 2022 |